Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease

Journal of Cardiovascular Pharmacology

Volumn 35, Issue SUPPL. 4, 2000, Pages

  Esler, M ^a   Kaye, D ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cardiac risk factor; Heart; Noradrenaline; Obesity; Panic disorder

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MOXONIDINE; NORADRENALIN; RILMENIDINE;

ADRENERGIC SYSTEM; BLOOD PRESSURE; CORONARY ARTERY BLOOD FLOW; DEPRESSION; ELECTROPHYSIOLOGY; ESSENTIAL HYPERTENSION; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; KIDNEY BLOOD FLOW; MENTAL STRESS; MUSCLE BLOOD FLOW; NEUROCHEMISTRY; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; OBESITY; PANIC; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; REVIEW; RISK FACTOR; SYMPATHETIC BLOCKING; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 0033652992     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200000004-00001     Document Type: Review

References (44)

1. Preliminary Report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
2. Antiadrenergic effect of chronic amiodarone therapy in human heart failure
3. Mental stress, panic disorder and the heart
4. Adverse consequences of high sympathetic nervous activity in the failing human heart
5. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
6. The cardiac insufficiency bisoprolol study II (CIBIS II): A randomised trial
7. Increased regional sympathetic nervous activity in human hypertension: Causes and consequences
8. Sympathetic activity in experimental and human hypertension
9. Changing role of the autonomic nervous system in human hypertension
10. Overflow of catecholamine neurotransmitters to the circulation: Source, fate and functions
11. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves
12. Spectral balance: A critical appraisal
13. How to assess sympathetic activity in humans
14. Maneuvers affecting sympathetic outflow in human skin nerves
15. Awareness of high blood pressure increases arterial plasma catecholamines, platelet norepinephrine and adrenergic responses to mental stress
16. The interconnection between sympathetics, microcirculation and insulin resistance in hypertension
17. Adrenergic effects on the biology of the adult mammalian cardiocyte
18. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias
19. Neural mechanisms in human obesity-related hypertension
20. Diet, obesity and hypertension: An hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis
21. Leptin is released from the human brain: Influence of adiposity and gender
22. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone
23. Slow- and intermediate-release nifedipine and sympathetic tone in essential hypertensive patients: A randomized double-blind crossover study
24. Relevance of intermittent increases in sympathetic activity for adverse outcome on short acting calcium antagonists
25. Myocardial norepinephrine concentration in man: Effects of reserpine and of congestive heart failure
26. Plasma norepinephrine in congestive heart failure
27. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
28. Catecholamines in patient with coronary heart disease
29. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity
30. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure
31. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure
32. The relationship of depression to cardiovascular disease
33. Symptoms of anxiety and coronary heart disease: The normative aging study
34. Job decision latitude, job demands, and cardiovascular disease: A prospective study of Swedish men
35. Sudden cardiac death triggered by an earthquake
36. The long QT interval syndrome. A rosetta stone for sympathetically mediated ventricular tachyarrhythmias
37. Prospective study of phobic anxiety and risk of coronary heart disease in men
38. Panic disorder: Coronary spasm as a basis for coronary risk?
39. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress and during panic attacks
40. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
41. Depression and 18-month prognosis after myocardial infarction
42. The peripheral kinetics of norepinephrine in depressive illness
43. Combined sympathetic suppression and angiotensin-converting enzyme inhibition in congestive heart failure
44. Preventive effect of rilmenidine on the occurrence of neurogenic ventricular arrhythmias in rabbits